Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
The State-of-the-Art Methodology Behind New Sickle Cell Disease Guidelines
source: American Society of Hematology
year: 2019
summary/abstract:Sickle cell disease (SCD) is an inherited blood disorder that affects the red blood cells and occurs when a person has inherited a sickle cell gene from each parent. The sickle-shaped red blood cells break apart easily, clump together, and stick to the walls of blood vessels, blocking the flow of blood and causing a range of complications, including severe pain, acute chest syndrome (a condition that affects the lungs), stroke, organ damage, and even premature death.
The American Society of Hematology (ASH) believes it is essential to provide updated treatment guidelines that reflect the newest evidence about the disease, ensuring the medical community can better treat SCD and people with SCD can make the best decisions for their care.
In partnership with the Evidence-Based Practice Research Program at Mayo Clinic, the 2019-2020 ASH Clinical Practice Guidelines on SCD were developed using the GRADE methodology to ensure the highest standards for trustworthiness.
read more
+myBinderRelated Content
-
Global Genes / Rare Foundation AllianceGlobal Genes® is a 501(c)(3) non-profit...
-
MARAC Advisory Statement: Gene Therapy & Bone Marrow TherapiesPlease note: A previous version of this ...
-
Sickle Cell Disease Coalition: Build Your Own SCD School BinderThe Build Your Own SCD School Binder off...
-
Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell diseaseAs defined by the American Physical Ther...
-
Think Beyond What You Seehttps://www.onescdvoice.com/wp-content/u...
-
Sickle Cell Warriors of WisconsinSickle Cell Warriors of Wisconsin is a v...
-
Toronto Neuroscientist Getting Closer to Tailored Treatments for Chronic PainDaily tasks most people don't think too ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.